Sirisha Kundrapu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sirisha Kundrapu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Annette L. Jencson
Research Service,Cleveland VA Medical Center,Cleveland,Ohio
1 shared publication- Curtis J. Donskey
Louis Stokes Cleveland VA Medical Center
1 shared publication H Jum’ah
Pathology, Metrohealth Medical Center/Case Western Reserve University, Cleveland, Ohio, UNITED STATES
1 shared publicationHeba Alhmidi
Research Service,Cleveland VA Medical Center,Cleveland,Ohio
1 shared publication- Jennifer L. Cadnum
Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA
1 shared publication M Chitsaz
Pathology, Metrohealth Medical Center/Case Western Reserve University, Cleveland, Ohio, UNITED STATES
1 shared publication
Latest Publications
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 156 (Supplement) , S162-S163
Leukostasis aggravated by red blood cell transfusion in a chronic lymphocytic leukemia patient
Leukostasis/symptomatic hyperleukocytosis is commonly seen in acute leukemias and is characterized by high blast counts and symptoms of decreased tissue perfusion with a one-week mortality of 20-40%, if left untreated. It is a rare complication in chronic lymphocytic leukemia (CLL) and is seen in CLL patients with white blood cell (WBC) counts > 500x10^9/L. Studies have shown that transfusion of blood products prior to decreasing the WBC count may lead to increased blood viscosity and worsen leukostasis. We report a CLL patient with a lower WBC count presenting with symptoms of leukostasis, further worsened by a red blood cell (RBC) transfusion prior to leukapheresis. A 73-year-old male with history of CLL for 5 years, hypertension and chronic kidney disease presented with acute dyspnea for 1 day. The WBC count was 208x10^9/L, hemoglobin was 6.5 g/dL, troponin I was 1.554 ng/mL, creatinine was 1.68 mg/dL and chest x-ray showed bilateral interstitial lung edema. The patient was diagnosed with acute hypoxic respiratory failure, acute kidney injury and myocardial infarction due to leukostasis. He received RBC transfusion, shortly after which his dyspnea worsened. There were no other signs or symptoms that could suggest a transfusion reaction. A single leukapheresis was performed following which there was a significant improvement in symptoms with a drop in WBC count to 123.1x10^9/L and creatinine to 1.3 mg/dL. NA CLL may present with symptomatic hyperleukocytosis at lower leukocyte counts than has been described in the literature. Symptoms due to leukostasis can be precipitated/worsened by transfusion of blood products due to increased blood viscosity. It is critical to identify the signs and symptoms of this medical emergency as prompt diagnosis and management with leukapheresis significantly reduces the leukocyte count and blood products should be transfused slowly during or after leukapheresis.
- 1 October 2021
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 156 (Supplement) , S162-S163
Open AccessLeukostasis aggravated by red blood cell transfusion in a chronic lymphocytic leukemia patient
Leukostasis/symptomatic hyperleukocytosis is commonly seen in acute leukemias and is characterized by high blast counts and symptoms of decreased tissue perfusion with a one-week mortality of 20-40%, if left untreated. It is a rare complication in chronic lymphocytic leukemia (CLL) and is seen in CLL patients with white blood cell (WBC) counts > 500x10^9/L. Studies have shown that transfusion of blood products prior to decreasing the WBC count may lead to increased blood viscosity and worsen leukostasis. We report a CLL patient with a lower WBC count presenting with symptoms of leukostasis, further worsened by a red blood cell (RBC) transfusion prior to leukapheresis. A 73-year-old male with history of CLL for 5 years, hypertension and chronic kidney disease presented with acute dyspnea for 1 day. The WBC count was 208x10^9/L, hemoglobin was 6.5 g/dL, troponin I was 1.554 ng/mL, creatinine was 1.68 mg/dL and chest x-ray showed bilateral interstitial lung edema. The patient was diagnosed with acute hypoxic respiratory failure, acute kidney injury and myocardial infarction due to leukostasis. He received RBC transfusion, shortly after which his dyspnea worsened. There were no other signs or symptoms that could suggest a transfusion reaction. A single leukapheresis was performed following which there was a significant improvement in symptoms with a drop in WBC count to 123.1x10^9/L and creatinine to 1.3 mg/dL. NA CLL may present with symptomatic hyperleukocytosis at lower leukocyte counts than has been described in the literature. Symptoms due to leukostasis can be precipitated/worsened by transfusion of blood products due to increased blood viscosity. It is critical to identify the signs and symptoms of this medical emergency as prompt diagnosis and management with leukapheresis significantly reduces the leukocyte count and blood products should be transfused slowly during or after leukapheresis.
- 5 April 2019
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 34 (5) , 528-536
Adverse events during apheresis: A 10‐year experience at a tertiary academic medical center
Background: Apheresis can be associated with adverse events (AEs). Available studies published on apheresis‐associated AEs lack uniformity of data. Unfortunately, there is no common database in the United States (US) to report apheresis‐associated AEs. We evaluated our institutional incidence of apheresis‐associated AEs and compared it with published literature.Study design and methods: We conducted a 10‐year retrospective study of apheresis procedures and associated AEs at our facility, a tertiary academic medical center, from 2007 to 2016. Concurrently, a literature search was conducted on AEs associated with apheresis procedures. Twenty‐eight studies including data from US and other countries' facilities were analyzed.Results: The overall AE incidence was 6.9% (396/5684 procedures). Frequency of AEs associated with therapeutic plasma exchange (TPE) was higher (8.5%, P < .0001) compared to other apheresis procedures. Significant correlation between number of TPE and AEs (Spearman rho [rs] = 0.7, P = .002) was encountered. Furthermore, there was a significant decrease over time of moderate and severe AEs (rs = −0.64, P = .04 and rs = −0.83, P = .003 respectively). Comparison of our institutional AEs (6.9%) to data from other countries (9.8%) and US (22.6%) indicated a significant difference (P < .0001).Conclusion: Overall our incidence of AEs was significantly lower than current published literature. Incidence of AEs published in other countries is significantly lower than US rates. Differences in incidence of AEs emphasize need for uniform reporting and stratification of AEs and development of a common database to report AEs. Therefore, we propose a grading rationale in order to standardize reporting of AEs.
- 5 April 2019
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 34 (5) , 528-536
Adverse events during apheresis: A 10‐year experience at a tertiary academic medical center
Background: Apheresis can be associated with adverse events (AEs). Available studies published on apheresis‐associated AEs lack uniformity of data. Unfortunately, there is no common database in the United States (US) to report apheresis‐associated AEs. We evaluated our institutional incidence of apheresis‐associated AEs and compared it with published literature.Study design and methods: We conducted a 10‐year retrospective study of apheresis procedures and associated AEs at our facility, a tertiary academic medical center, from 2007 to 2016. Concurrently, a literature search was conducted on AEs associated with apheresis procedures. Twenty‐eight studies including data from US and other countries' facilities were analyzed.Results: The overall AE incidence was 6.9% (396/5684 procedures). Frequency of AEs associated with therapeutic plasma exchange (TPE) was higher (8.5%, P < .0001) compared to other apheresis procedures. Significant correlation between number of TPE and AEs (Spearman rho [rs] = 0.7, P = .002) was encountered. Furthermore, there was a significant decrease over time of moderate and severe AEs (rs = −0.64, P = .04 and rs = −0.83, P = .003 respectively). Comparison of our institutional AEs (6.9%) to data from other countries (9.8%) and US (22.6%) indicated a significant difference (P < .0001).Conclusion: Overall our incidence of AEs was significantly lower than current published literature. Incidence of AEs published in other countries is significantly lower than US rates. Differences in incidence of AEs emphasize need for uniform reporting and stratification of AEs and development of a common database to report AEs. Therefore, we propose a grading rationale in order to standardize reporting of AEs.
- 15 March 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (6) , 711-713
Utility of a Novel Reflective Marker Visualized by Flash Photography for Assessment of Personnel Contamination During Removal of Personal Protective Equipment
In an experimental study, the frequency of contamination of healthcare personnel during removal of contaminated personal protective equipment (PPE) was similar for bacteriophage MS2 and a novel reflective marker visualized using flash photography. The reflective marker could be a useful tool to visualize and document personnel contamination during PPE removal.Infect Control Hosp Epidemiol 2016;37:711–713
- 15 March 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (6) , 711-713
Utility of a Novel Reflective Marker Visualized by Flash Photography for Assessment of Personnel Contamination During Removal of Personal Protective Equipment
In an experimental study, the frequency of contamination of healthcare personnel during removal of contaminated personal protective equipment (PPE) was similar for bacteriophage MS2 and a novel reflective marker visualized using flash photography. The reflective marker could be a useful tool to visualize and document personnel contamination during PPE removal.Infect Control Hosp Epidemiol 2016;37:711–713